These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26575790)

  • 41. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.
    Nikolova DA; Asangani IA; Nelson LD; Hughes DP; Siwak DR; Mills GB; Harms A; Buchholz E; Pilz LR; Manegold C; Allgayer H
    Cancer Res; 2009 Mar; 69(6):2461-70. PubMed ID: 19276367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
    Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
    Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
    Xue X; Liu Y; Wang Y; Meng M; Wang K; Zang X; Zhao S; Sun X; Cui L; Pan L; Liu S
    Oncotarget; 2016 Dec; 7(51):84508-84519. PubMed ID: 27811366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testin is a tumor suppressor in non-small cell lung cancer.
    Wang M; Wang Q; Peng WJ; Hu JF; Wang ZY; Liu H; Huang LN
    Oncol Rep; 2017 Feb; 37(2):1027-1035. PubMed ID: 28000866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.
    Wang CY; Chen CL; Tseng YL; Fang YT; Lin YS; Su WC; Chen CC; Chang KC; Wang YC; Lin CF
    J Biol Chem; 2012 Sep; 287(39):32512-24. PubMed ID: 22859294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
    Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
    Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
    Liu M; Zhou K; Huang Y; Cao Y
    J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
    Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
    Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
    Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
    Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
    J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.